Decline depth
-57.6%
From rolling 252-day high of $44.60, 141d ago.
Past the 40% Red List threshold.
-57.6%
from rolling 252-day high of $44.60 set 2025-12-24 · 141d ago
Current
$18.90
Decline depth
-57.6%
Decline σ
2.9σ
TFC
2/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Structural break signals
ZBIO qualifies for the Red List on decline depth.
Time-frame continuity
2/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
2.9σ
Drop from local high over the last 10 bars, expressed in units of the stock's typical daily volatility (5.15% per day).
The structural read
What price action says about ZBIO.
ZBIO qualifies for the Red List on decline depth — down -57.6% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy.
52-week range
52W low $8.51
28.8% of range
52W high $44.60
Sector context · Healthcare
182 other Healthcare tickers are on Broken Stocks.
92
Red List
43
Amber
47
Watch
-35.8%
Median decline
Worst in sector: OPRX (-76.7%). Least-bad: ANIP (-20.0%). See all Healthcare listings →
Related — same sector
Closest decliners to ZBIO
Red List Recovering
CLPT
ClearPoint Neuro Inc.
Red List
SRPT
Sarepta Therapeutics, Inc.
Red List
CSTL
Castle Biosciences, Inc.
Red List
SPRY
ARS Pharmaceuticals, Inc.
Red List
PODD
Insulet Corporation
Red List
TEM
Tempus AI, Inc.
Questions about ZBIO
What people ask.
Why is ZBIO on Broken Stocks?
ZBIO qualifies for the Red List on decline depth. It is down -57.6% from its rolling 252-day high of $44.60, set on 2025-12-24 — 141d ago.
Is ZBIO a falling knife?
Not by the strict technical definition. ZBIO is down -57.6% from its 52-week high, but that high was set 141d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. ZBIO is still on the Red List for decline depth, but the freshness component of a falling knife is missing.
Is ZBIO a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is ZBIO trading inside its 52-week range?
At $18.90, ZBIO sits 28.8% of the way from its 52-week low ($8.51) to its 52-week high ($44.60). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has ZBIO been declining?
The current 57.6% decline accrued over 141d, which annualizes to roughly -149.1% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does ZBIO compare to its sector?
There are 182 other Healthcare tickers on Broken Stocks: 92 Red, 43 Amber, 47 Watch, with 55 showing recovering structural signals. Median sector decline is -35.8% — ZBIO's decline is deeper than the sector median.